The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 24, 2021

Filed:

Apr. 23, 2018
Applicants:

Venugopala Chokkasandra Jayaramareddy, Hyderabad, IN;

Sreenivas Reddy, Hyderabad, IN;

Chandrashekhar Shriram Kandi, Hyderabad, IN;

Sivakumaran Meenakshisunderam, Hyderabad, IN;

Inventors:
Assignee:

Aurobindo Pharma Ltd, Hyderabad, IN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/522 (2006.01); A61K 9/51 (2006.01); A61K 9/50 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/522 (2013.01); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/2077 (2013.01); A61K 9/2826 (2013.01); A61K 9/2866 (2013.01); A61K 9/5047 (2013.01); A61K 9/5089 (2013.01); A61K 9/5123 (2013.01); A61K 9/5138 (2013.01); A61K 9/5161 (2013.01);
Abstract

Pharmaceutical compositions comprising an antidiabetic agent as an active agent are provided. The present invention relates to pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof as an active agent. The present invention also relates to process of preparation of pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof. The present invention also relates to method of administering the compositions comprising linagliptin to a subject in need thereof.


Find Patent Forward Citations

Loading…